RCM
INSM icon

Requisite Capital Management’s Insmed INSM Stock Holding History

Requisite Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25,000
Closed -$678K – 85
2024
Q1 		$678K Buy
+25,000
New +$700K 0.15% 40
2022
Q4 		– Sell
-20,000
Closed -$431K – 66
2022
Q3 		$431K Hold
20,000
– – 0.15% 29
2022
Q2 		$394K Hold
20,000
– – 0.13% 42
2022
Q1 		$470K Buy
+20,000
New +$465K 0.14% 48

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Requisite Capital Management's INSM Position: Q2 2024 in Review

Requisite Capital Management sold out of Insmed (INSM) in Q2 2024, closing a stake of 25,000 shares — an estimated $678K sold.

Requisite Capital Management first reported a position in INSM in Q1 2022 and held it in 4 quarters. The position peaked at $678K in Q1 2024. 378 funds tracked by Wall St. Rank hold INSM as of Q2 2024.

  • Requisite Capital Management reported no remaining Insmed position as of Q2 2024 after selling out during the quarter.
  • Requisite Capital Management sold 25,000 Insmed shares in Q2 2024, an estimated $678K.
  • Requisite Capital Management first reported a position in Insmed in Q1 2022 and held it in 4 quarters.
  • Requisite Capital Management's Insmed position peaked at $678K in Q1 2024.
  • 378 funds tracked by Wall St. Rank held Insmed as of Q2 2024.

Based on Requisite Capital Management's 13F filing for Q2 2024, filed 2 Aug 2024.